Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of IgG (Fc) monoclonal antibody, clone EM-07
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Mouse |
| Applications | ELISA,ICC,WB-Ti |
More info about IgG (Fc) monoclonal antibody, clone EM-07
| Brand: | Abnova |
| Reference: | MAB6465 |
| Product name: | IgG (Fc) monoclonal antibody, clone EM-07 |
| Product description: | Mouse monoclonal antibody raised against IgG (Fc). |
| Clone: | EM-07 |
| Isotype: | IgG1 |
| Immunogen: | Fusion protein of human IgG Fc fragment. |
| Form: | Liquid |
| Recommend dilutions: | The optimal working dilution should be determined by the end user. |
| Storage buffer: | In PBS, pH 7.4 (0.09% sodium azide) |
| Storage instruction: | Store at 4°C. Do not freeze. Aliquot to avoid repeated freezing and thawing. |
| Note: | This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
| Product type: | Primary antibodies |
| Host species: | Mouse |
| Antigen species / target species: | Human |
| Specificity: | This antibody reacts with Fc part of human IgG heavy chain and with isolated Fc fragments. |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | IgG, kappa light chain (Lane 1), IgG lambda light chain (Lane 2) and IgG Fc fragment (Lane 3) purified from human serum were analysed by Western blotting with Kappa light chains monoclonal antibody, clone MEM-09 (Cat # MAB6445) (Panel A) and IgG (Fc) monoclonal antibody, clone EM-07 (Cat # MAB6465) (Panel B). |
| Applications: | ELISA,ICC,WB-Ti |
| Shipping condition: | Blue Ice |
| Publications: | Serum immunoglobulins after surgical operation.Fuller JM, Keyser JW. Clin Chem. 1975 May;21(6):667-71. |